Sigyn Therapeutics (SIGY) Operating Expenses (2017 - 2025)

Sigyn Therapeutics has disclosed Operating Expenses across 9 years of filings, most recently posting $386529.0 for Q3 2025.

• In Q3 2025, Operating Expenses fell 52.19% year-over-year to $386529.0; the TTM figure through Sep 2025 stood at $1.9 million (down 31.84% YoY), while the FY2024 annual figure was $2.5 million, up 2.6% from the prior year.
• Operating Expenses came in at $386529.0 for Q3 2025 at Sigyn Therapeutics, down from $469513.0 in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $808458.0 in Q3 2024 to a low of $386529.0 in Q3 2025.
• Average Operating Expenses over 5 years is $554323.4, with a median of $546059.0 recorded in 2025.
• Year-over-year, Operating Expenses surged 182.48% in 2021 and sank 52.19% in 2025.
• Over 5 years, Operating Expenses stood at $590939.0 in 2021, then slipped by 20.2% to $471588.0 in 2022, then jumped by 52.09% to $717236.0 in 2023, then tumbled by 33.35% to $478010.0 in 2024, then slipped by 19.14% to $386529.0 in 2025.
• Per Business Quant data, the three most recent Operating Expenses figures were $386529.0 in Q3 2025, $469513.0 in Q2 2025, and $546059.0 in Q1 2025.